TRIF/TICAM-1 (TIR domain-containing adaptor inducing interferon-/TIR domain-containing adaptor molecule 1) is the adaptor protein in the Toll-like receptor (TLR) 3 and 4 signalling pathway that leads to the production of type 1 interferons and cytokines. The signalling involves TIR (Toll/ interleukin-1 receptor) domain-dependent TRIF oligomerization. A protease-resistant N-terminal region is believed to be involved in self-regulation of TRIF by interacting with its TIR domain. Here, the structural and functional characterization of the N-terminal domain of TRIF (TRIF-NTD) comprising residues 1-153 is reported. The 2.22 Å resolution crystal structure was solved by single-wavelength anomalous diffraction (SAD) using selenomethionine-labelled crystals of TRIF-NTD containing two additional introduced Met residues (TRIF-NTD A66M/L113M ). The structure consists of eight antiparallel helices that can be divided into two subdomains, and the overall fold shares similarity to the interferon-induced protein with tetratricopeptide repeats (IFIT) family of proteins, which are involved in both the recognition of viral RNA and modulation of innate immune signalling. Analysis of TRIF-NTD surface features and the mapping of sequence conservation onto the structure suggest several possible binding sites involved in either TRIF auto-regulation or interaction with other signalling molecules or ligands. TRIF-NTD suppresses TRIF-mediated activation of the interferonpromoter, as well as NF-B-dependent reporter-gene activity. These findings thus identify opportunities for the selective targeting of TLR3-and TLR4-mediated inflammation.
Introduction
The innate immune system constitutes the first line of defence against microbial infection or endogenous danger signals. Pathogen-associated or danger-associated molecular patterns (PAMPs/DAMPs) are recognized by pattern-recognition receptors (PRRs) such as the membrane-bound Toll-like and C-type lectin receptors (TLRs and CLRs) or the cytosolic NOD-like and RIG-I-like receptors (NLRs and RLRs) (Bonardi et al., 2012; Eisenä cher & Krug, 2012; Kawai & Akira, 2010; Kingeter & Lin, 2012) . After PAMP/DAMP recognition, these receptors recruit specific adaptor proteins that determine the specificity of inflammatory response via the activation of distinct transcription factors and pro-inflammatory genes (Werts et al., 2006; Ve et al., 2012) .
TLRs are the best-characterized members of the PRR family and recognize PAMPs such as lipopolysaccharides, lipopeptides or bacterial flagellin at the surface of immune cells, while viral or microbial nucleic acids are recognized by endosomally localized TLRs (Barton & Kagan, 2009 ). TLRs contain a PAMP-recognizing leucine-rich repeat (LRR) domain, a transmembrane helix and a cytosolic TIR (Toll/ interleukin-1 receptor) domain involved in TIR-TIR domain interactions. PAMP binding leads to oligomerization of TLRs and consequently their TIR domains, which facilitates the recruitment of cytosolic TIR domain-containing adaptor proteins and signalling. The selective recruitment of one or several adaptors to specific TLRs triggers the activation of distinct signalling pathways (O'Neill & Bowie, 2007; Akira et al., 2006; Ve et al., 2012) . TRIF/TICAM-1 (TIR domaincontaining adaptor inducing interferon-/TIR domaincontaining adaptor molecule 1) is directly recruited to TLR3, while association with TLR4 requires the TIR domaincontaining bridging adaptor TRAM/TICAM-2 (TRIF-related adaptor molecule/TIR domain-containing adaptor molecule 2). TRIF orchestrates a signalling response characterized by the inducible expression of interferon-(IFN) and IFNdependent genes via the activation of the transcriptional factors IRF-3, NF-B and AP-1 Yamamoto et al., 2003; Fitzgerald et al., 2003; Oshiumi, Sasai et al., 2003) .
In the cytoplasm of resting cells, TRIF is expressed at a low level in a diffuse form Funami et al., 2007) , while in poly(I:C)-stimulated cells TRIF first transiently associates with TLR3 and subsequently (after dissociation from the receptor) forms speckle-like structures that also contain downstream signalling molecules (Funami et al., 2007; Tatematsu et al., 2010) . Human TRIF (712 amino acids) consists of an N-terminal protease-resistant domain with a predicted helical structure followed by a proline-rich unstructured region containing TBK1 (TANK-binding kinase) and TRAF6 (tumour necrosis factor receptor-associated factor 6) binding motifs, a central TIR domain and a C-terminal region containing an RIP homotypic interaction motif (RHIM) (Fig. 1 ). Both the TIR and the RHIM domains are required for TRIF homo-oligomerization (Funami et al., 2008) . The TIR domain also facilitates the direct interaction with TLR3 and TRAM through TIR-TIR domain interactions, while heterotypic RHIM-RHIM domain interactions enable TRIF to associate with the death domain-containing kinases RIP1 and RIP3, leading to NF-B activation and cell death (Meylan et al., 2004; Han et al., 2004; Kaiser & Offermann, 2005; He et al., 2011) . Recruitment of TRAF6 also results in NF-B activation (Sasai et al., 2010) , while binding of TBK1 leads to IRF-3 activation and IFN induction Han et al., 2010) . Several regulatory molecules [for example, members of the tripartite motif (TRIM) family of proteins] further regulate the signalling either positively or negatively to maintain a balanced response, as both overactivation and underactivation of TRIFmediated signalling have undesirable effects. The molecular mechanisms of the interaction of TRIF with its binding partners are unknown.
A deletion mutant of TRIF lacking the N-terminal protease-resistant domain (residues 1-176) has a higher ability for IFN promoter activation compared with wild-type TRIF and forms speckle-like structures in resting cells . Immunoprecipitation and protein-fragment complementation analyses have shown that the TRIF N-terminal domain interacts with the TIR domain, which suggests that it can fold back onto the TIR domain in the resting state of TRIF, and acts as a negative regulator preventing downstream signalling molecules such as TBK1, RIP1/3 and TRAF6 from accessing their binding sites.
To understand the molecular basis of TRIF auto-regulation, we solved the crystal structure of the N-terminal domain of TRIF (TRIF-NTD) at 2.22 Å resolution. The structure contains eight antiparallel -helices that can be divided into two subdomains by a long linker region. The overall fold of TRIF-NTD shares significant structural similarity to the IFNinduced protein with tetratricopeptide repeats (IFIT) family of proteins, which have been shown to bind viral RNA and to regulate innate immune responses by modulating interactions between components in the type 1 IFN signalling pathway. Analysis of the structure reveals specific surface regions that could be involved in TRIF auto-regulation or interact with other signalling molecules or ligands. Reporter assays in transfected cells show that TRIF-NTD suppresses TRIFmediated induction of both the IFN promoter and an NF-B-dependent promoter, and could therefore serve as an experimental tool and therapeutic reagent for targeting TLR3-and TLR4-mediated inflammation.
Materials and methods

Structure determination and refinement
Details of the expression, purification and X-ray diffraction data collection of TRIF-NTD have been reported previously (Ullah et al., 2013) . In brief, we crystallized the N-terminal protein fragment of TRIF encoding residues 1-153 (TRIF-NTD). The structure was solved by single-wavelength anomalous diffraction (SAD) using selenomethionine-labelled crystals of TRIF-NTD containing two additional Met residues (TRIF-NTD A66M/L113M ). X-ray diffraction data sets were collected at two wavelengths [1.1070 Å (high-resolution data Schematic representation of the primary structure of TRIF, highlighting structural and functional motifs. TRIF-NTD (TRIF N-terminal domain) is a globular domain consisting of eight helices (this work). TBK1-BM (TANK-binding kinase 1 binding motif) corresponds to residues 191-200 . TRAF6-BM (TRAF6-binding motif) and TRAF2-BM (TRAF2-binding motif) correspond to residues 230-235 and 333-338, respectively (Sasai et al., 2010) . Residues 390-538 are predicted to correspond to a TIR domain. An RHIM (receptor-interacting protein homotypic interaction motif) is found in the C-terminal region of TRIF (Meylan et al., 2004) . set) and 0.9793 Å (Se peak data set)] and the resolution limits of the data sets corresponded to 2.22 and 2.48 Å , respectively. The data for the high-resolution data set could not be used to a resolution higher than 2.22 Å because of a rapid drop in data completeness owing to the geometry of data collection. The crystals had the symmetry of space group P1 with four molecules in the asymmetric unit. SAD phasing was performed using the Se peak data set and the program AutoSol in the PHENIX suite (Adams et al., 2013 ). The initial model was built into the resulting density using ARP/wARP (Langer et al., 2008) and several cycles of refinement were performed using phenix.refine in the PHENIX suite with model building using Coot (Emsley et al., 2010) using the highresolution data set. Programs from the CCP4 suite (Winn et al., 2011) were also used at different stages of structure determination. Crystals of wild-type TRIF-NTD diffracted X-rays to resolutions between 1.9 and 2.8 Å . The data from these crystals were originally processed in space group P2 1 2 1 2 1 , with unit-cell parameters a = 48.02, b = 77.18, c = 85.15 Å (Ullah et al., 2013) , and although a molecularreplacement solution could be found using Phaser (McCoy et al., 2007) with the TRIF-NTD A66M/L113M structure as a template, the model could not be refined (R work > 44% and R free > 48%). However, the data from one of the TRIF NTD crystals that diffracted X-rays to 2.8 Å resolution could also be processed in space group P1 with a similar unit cell to TRIF-NTD A66M/L113M . This structure was solved using molecular replacement and refined using BUSTER-TNT (Blanc et al., 2004) to final R work and R free values of 25.2 and 29.1%, respectively. Comparison of the packing of the molecules in the crystals of the P2 1 2 1 2 1 symmetry wild-type TRIF-NTD, based on the possible molecular-replacement solution, with those in the crystals of the P1 symmetry TRIF-NTD and TRIF-NTD A66M/L113M revealed a related but not identical arrangement of molecules. We suggest that the packing of molecules in the crystals deviates slightly from an arrangement that would be compatible with higher (space group P2 1 2 1 2 1 ) crystallographic symmetry (i.e. such that the symmetry axes relating the molecules could be propagated in the crystal as crystallographic symmetry). PyMOL (http:// www.pymol.org) and Pro-origami (Stivala et al., 2011) were used to generate the figures. Coordinates and structure factors for TRIF-NTD A66M/L113M and wild-type TRIF-NTD have been deposited in the Protein Data Bank as entries 4bsx and 4c0m, respectively.
Analysis of the structure
The structure was compared with available structures using DALI (Holm & Rosenströ m, 2010) . The electrostatic potential was mapped onto the surface using APBS (Unni et al., 2011) . Multiple sequence alignments were performed using ClustalW (Larkin et al., 2007) and formatted using ESPript (Gouet et al., 2003) . Interfaces were analyzed using the PISA server (Krissinel & Henrick, 2007) ; the buried surface areas reported correspond to the total buried surface area contributed by both interacting partners.
Transient transfection of cells and reporter activity
Human embryonic kidney (HEK) 293 cells were incubated in Dulbecco's modified Eagle's medium supplemented with 10% foetal calf serum, 2 ml glutamine and maintained in a 310 K humidified atmosphere. The cells (2 Â 10 4 ml À1 ) were seeded in 96-well plates 24 h prior to transfection. Transfections were performed with Fugene 6 (Roche Diagnostics). NF-B-dependent reporter-gene expression was determined using the 5Â B-luciferase reporter construct (Stratagene) concomitantly with the indicated vectors. The p125-luc luciferase plasmid contains the full-length IFN promoter upstream of the firefly luciferase gene and is referred to as the IFN-luciferase reporter. The Renilla luciferase-thymidine kinase-encoding plasmid (pRL-TK; Promega, Madison, Wisconsin, USA) was used to normalize for transfection efficiency and pEF-BOS empty vector was used to maintain constant amounts of DNA. Cells transfected with pEF-Bos-TRAM, pEF-Bos-TRIF and Flag-tagged TLR3 either in the presence or absence of TRIF-NTD (in a pEF6/V5-His-TOPO vector) were lysed using Passive Lysis Buffer (Promega) and assayed for luciferase and Renilla luciferase activity using the Renilla Luciferase Assay System reagent (Promega). Luminescence readings were corrected for Renilla luciferase activity and expressed as fold increases over nonstimulated control values.
Biophysical analyses
MALLS (multi-angle laser light scattering) experiments were carried out using a DAWN HELEOS II 18-angle lightscattering detector coupled with an Optilab rEX refractiveindex detector (Wyatt Technology) and combined inline with a Superdex 200 10/300 GL (GE Healthcare) size-exclusion column connected to a Prominence UFLC (Shimadzu). The buffer for all experiments corresponded to 10 mM HEPES pH 7.5, 150 mM NaCl, 2 mM DTT. For circular-dichroism (CD) analyses, the protein samples were prepared by dialysis overnight into 10 mM phosphate buffer pH 7.5, 100 mM NaCl. The concentrations of the proteins were in the range 4-5 mM. The CD spectra were collected using a Jasco J710 spectropolarimeter at 298 K. The measurements were recorded at 0.2 nm wavelength increments from 260 to 195 nm at 20 nm min À1 using a 0.1 cm path-length cell, a 1 nm bandwidth, a 1 s response time and five accumulations. After correction for the buffer baseline contribution, the spectra were analyzed using the online programs CAPITO (Wiedemann et al., 2013) and SOMCD (Unneberg et al., 2001) .
Results and discussion
3.1. Functional characterization of TRIF-NTD TRIF-NTD has previously been proposed to form an intramolecular interaction with the TIR domain of TRIF, thus preventing the homodimerization of TRIF and binding to downstream signalling molecules . We therefore tested whether TRIF-NTD could act functionally as a dominant negative to inhibit TRIF-induced signalling using research papers the TRIF-NTD construct structurally characterized in this study (TRIF-NTD, comprising residues 1-153). Expression of TRIF-NTD did not activate either the IFN or the NF-B promoter ( Supplementary Fig. S1a 1 ) . We first established a dose of TRIF that activated both the NF-B and IFNluciferase promoters and chose 1 ng of TRIF DNA as a suboptimal activating dose, such that we would observe any inhibition of signalling ( Supplementary  Fig. S1b ). Ectopic expression of TRIF-NTD in a 25-fold to 100-fold excess compared with TRIF was able to inhibit both TRIF-mediated IFN promoter activation ( Fig. 2a, left panel) and TRIF-induced NF-B promoter activity ( Fig. 2a, right panel) .
To provide further support for the observed effects of TRIF-NTD on TRIF-mediated signalling, we demonstrated that TRIF-NTD is able to inhibit TRAM-induced IFN or NF-B promoter activation (left and right panels in Fig. 2b, respectively) . We also assessed the ability of TRIF-NTD to suppress TLR3-mediated activation of signalling pathways. As can be observed in Fig. 2(c) , TRIF-NTD noticeably and consistently inhibited the degree of TLR3-induced IFN (left panel) and NF-B (right panel) promoter activation, particularly at higher doses.
Importantly, we were successful in suppressing TRAM-induced activation of the signalling pathway by TRIF-NTD. As TRAM is an upstream activator of TRIF, the ability of TRIF-NTD to suppress signalling implies that excess TRIF-NTD is able to compete with subsequent activation of TRIF to suppress downstream signalling. This therefore suggests that the association between TRIF-NTD and the TIR domain of TRIF is dynamic and could be suppressed through molecular competition if excess TRIF-NTD is available during activation.
Taken together, our results support the theory of Matsumoto and coworkers that excess expression of TRIF-NTD acts to suppress the activity of TRIF and modulates the downstream signalling pathways leading to activation of both the IFN or NF-B promoters. These results suggest that therapeutically targeting TRIF-mediated signalling with excess TRIF-NTD could potentially modulate TLR3-or TLR4-mediated signal transduction and inflammation. 
Structure determination of TRIF-NTD
To aid in understanding its function and in any therapeutic application, we set out to structurally characterize TRIF-NTD. Constructs encompassing residues 1-153 and 1-177 of human TRIF were produced in Escherichia coli and purified using a combination of IMAC (immobilized metal-ion affinity chromatography) and gel filtration. Both constructs crystallized, but only the shorter construct produced diffraction-quality crystals (Ullah et al., 2013) . The N-terminal region of TRIF does not share sequence similarity to any proteins of known structure and only contains two methionine residues. To increase the chances of successful structure determination using SeMetbased experimental phasing, Ala66 and Leu113 were mutagenized to methionine residues (TRIF-NTD A66M/L113M ). These positions correspond to methionine residues in several mammalian TRIF orthologues (Ullah et al., 2013) . The remaining parts of the sequences are highly conserved, suggesting that these mutations should not affect the overall fold of the protein. TRIF-NTD, TRIF-NTD A66M/L113M and TRIF (residues 1-177) are all monomeric in solution (based on MALLS analysis; Supplementary Fig. S2 ) and have indistinguishable circular-dichroism spectra ( Supplementary Fig. S3 ). SeMetlabelled TRIF-NTD A66M/L113M was successfully purified and yielded platelike crystals which diffracted X-rays to 2.22 Å resolution. The crystals had the symmetry of the triclinic space group P1. An interpretable electron-density map was obtained from an SeMetlabelled derivative using the singlewavelength anomalous diffraction (SAD) technique. The structure was refined to final R work and R free values of 19 and 24%, respectively, with good stereochemistry ( Table 1 ). The final model contains four nearly identical molecules in the asymmetric unit [the maximum root-mean-square distance (r.m.s.d.) for any pair of the molecules was 0.189 Å for all atoms]. The model contains residues 4-148; no electron density was observed for residues 1-3 and 149-153, suggesting that these regions have a disordered or flexible conformation in the crystal. For wild-type TRIF-NTD we have only been able to obtain Table 1 Structure-solution and refinement statistics.
TRIF-NTD A66M/L113M
High-resolution data set Se peak data set TRIF-NTD is the ith measurement of the intensity of reflection khl, hI(hkl)i is the mean intensity of reflection hkl and N(hkl) is the number of observations of intensity I(hkl) (the multiplicity). ‡ R p.i.m. = P hkl f1=½NðhklÞ À 1g 1=2 P i jI i ðhklÞ À hIðhklÞij= P hkl P i I i ðhklÞ. § An estimate of phase quality and an indicator of the internal consistency of a solution, ranging from 0 to 1. } The Bayesian correlation coefficient score. Bayesian estimates of the quality of experimental electron-density maps are obtained using data from a set of previously solved data sets. † † Skew of the electron density in the map. ‡ ‡ The correlation of local r.m.s density. § § R work = P hkl jF obs j À jF calc j = P hkl jF obs j, where F obs and F calc are the observed and calculated structure factors, respectively. }} R free is equivalent to R work but was calculated using a randomly selected 7.3% of the reflections, which were excluded from all stages of refinement. diffraction data to 2.8 Å resolution (Table 1) . Importantly, there are no significant differences between the structures of wild-type TRIF-NTD and TRIF-NTD A66M/L113M (r.m.s.d. of 0.32 Å for all four chains in the asymmetric unit; Supplementary Fig. S4 ); we will therefore use the higher resolution structure of TRIF-NTD A66M/L113M for all structural analyses in this paper unless stated otherwise. Representative electron-density maps are shown in Supplementary Fig. S5 .
Overall structure of TRIF-NTD
The crystal structure of TRIF-NTD consists of eight -helices (1-8) connected by loop regions (Figs. 3a, 3b  and 3c ). The structure can be divided into three parts: the N-terminal 79 residues form an antiparallel five-helix structure and residues 92-148 form an antiparallel three-helix bundle, while residues 80-91 form a long linker loop connecting the two subdomains. Although the linker region separates the two subdomains, they form extensive interactions with each other, as indicated by the buried surface area of about 1520 Å 2 . These interactions involve both hydrophobic and polar residues, contributed predominantly by helices 1-3 in the first subdomain and helices 7-8 in the second subdomain. Several of these residues are conserved in TRIF variants from mammals, fish and birds (Fig. 4 ). One distinct interface was observed between two molecules in the TRIF-NTD crystals, yielding a dimeric structure with overall dimensions of 72 Â 44 Â 38 Å and a buried surface area of approximately 1700 Å 2 ( Supplementary Fig. S6 ). However, analysis of the interface using PISA (Krissinel & Henrick, 2007) revealed very few specific side-chain interactions, suggesting that the interface is likely to correspond to a nonspecific crystal-packing interface, which is consistent with MALLS (multi-angle laser light scattering) data showing that TRIF-NTD exists as a monomer in solution (Supplementary Fig. S1 ; Ullah et al., 2013) . Examination of the electrostatic surface potential of TRIF-NTD revealed that the charge is distributed unevenly, with the surface areas contributed by the 3-5 and 7-8 helices and the long loop connecting the 5 and 6 helices having an overall electronegative charge, while the face of the molecule contributed by the 2 helix and the tip of the 6 helix is positively charged (Fig. 5 ). 
Figure 4
Multiple sequence alignment of TRIF orthologues. Amino-acid sequences were aligned using ClustalW (Larkin et al., 2007) . The positions of the elements of secondary structure in TRIF-NTD are shown at the top. The alignment was formatted using ESPript (Gouet et al., 2003) . Strictly conserved residues are indicated in white letters on a red background, while similar residues are indicated in red letters in a blue frame. (a) Alignment of the N-terminal regions of mammalian TRIF orthologues. (b) Alignment of the N-terminal regions of human, chicken and zebra-fish TRIF proteins.
TRIF-NTD shares structural similarity with IFIT proteins
A search for structurally similar proteins using DALI (Holm & Rosenströ m, 2010) identified significant similarities to tetratricopeptide repeat (TPR) containing proteins, including IFN-induced proteins with tetratricopeptide repeats (IFIT) 1 (DALI Z score = 4.4) and 5 (Z = 3.7), the mitochondrial fission protein 1 (Fis1; Z = 3.5), and microtubule interacting and transport (MIT) domaincontaining proteins such as the VPS4 ATPase (Z = 3.0) and katanin p60 (Z = 2.6) (Supplementary Fig. S7 ). TPR is a structural motif that is present in a wide range of proteins and is involved in mediating proteinprotein interactions and multiprotein complex assembly (D'Andrea & Regan, 2003) . The MIT domain is also involved in protein-protein interactions, and the orientation and the inter- Colouring is continuous from blue (potential +5kT/e) through white to red (potential À5kT/e). (e) The surface is coloured according to the hydrophobicity of the side chain, with yellow representing hydrophobic residues and blue representing residues with polar side chains. In (a) to (e) the molecules in the central and right panels have been rotated relative to the molecule in the left panel.
helical interactions between the two first helices share a similarity to TPR motifs (Scott et al., 2005) . The TPR motif is $34 amino acids in length and contains two antiparallel helices (helix A and helix B) with eight loosely conserved positions, Trp4, Leu7, Gly8, Tyr11, Ala20, Phe24, Ala27 and Pro32, which mediate the interaction between the two helices (Blatch & Lä ssle, 1999) . In TRIF-NTD, the helix pairs 3-4 and 6-7 resemble TPR motifs, with amino acids typical for TPRs found at positions 8, 11, 20, 24 and 27 in the first motif, and 8, 11, 24 and 27 in the second motif (Fig. 3d ). Not surprisingly, these two helix pairs and their succeeding helices (5 and 8) are structurally similar to each other, with an r.m.s.d. of 1.4 Å for 42 equivalent C atoms (Fig. 3e ). However, the two motifs do not form a continuous repetitive structure in TRIF-NTD. The TPR-containing IFIT proteins have the highest level of similarity to TRIF-NTD, with overall r.m.s.d. values of 3.2 and 3.4 Å (for 116 and 120 equivalent C atoms) for IFIT1 and IFIT5, respectively ( Fig. 6, Supplementary Fig. S8 ). Structurally, IFIT proteins can be divided into three TPR-containing regions (Yang et al., 2012; Abbas et al., 2013) ; in IFIT1 and IFIT5 helices 1-6 form the N-terminal subdomain and helices 7-14 form the central subdomain, while the remaining helices form the C-terminal subdomain (Fig. 6a ). The first subdomain in TRIF-NTD aligns well with the first five helices of the N-terminal subdomain of IFIT1, IFIT2 and IFIT5 (r.m.s.d. of 2.32 Å for 65 equivalent C atoms for IFIT1), while the second subdomain in TRIF-NTD aligns well with the three first helices of the central subdomain in IFIT1, IFIT2 and IFIT5 (r.m.s.d. of 2.5 Å for 43 equivalent C atoms for IFIT1; Figs. 6b and 6c, Supplementary Fig. S8 ). The relative positions of the N-terminal and central subdomains in IFIT proteins are also conserved in TRIF-NTD (Fig. 6c) . In both the TRIF-NTD and the IFIT proteins the first helix of the second subdomain packs against the concave surface of the N-terminal domain, which is reminiscent of the interaction between the TPR-containing protein Fis1 and its ligand (Zhang & Chan, 2007) . Interestingly, in the crystal structure of IFIT2 (Yang et al., 2012) the N-terminal subdomain and the three first helices of the central subdomain from two different molecules associate to form a domain-swapped dimer and may explain how IFIT proteins form homo and hetero complexes. However, it is unlikely that TRIF-NTD would form similar domain-swapped dimers as this region of TRIF is not required for homo-oligomerization .
IFIT proteins are encoded by a family of genes that are highly induced after stimulation by IFNs, viral infection and PAMP recognition and can inhibit viral infection by suppression of translation initiation and by sequestering of viral proteins or RNA in the cytoplasm (Diamond & Farzan, 2013) . IFIT proteins modulate interactions between signalling proteins in the type 1 IFN pathway. IFIT1 has been shown to disrupt the physical interaction between STING (stimulator of IFN genes protein) and TBK1 or MAVS (mitochondrial antiviral-signalling protein) (Li et al., 2009) , while IFIT3 can bridge the interaction between MAVS and TBK1, leading to an elevated antiviral response (Liu et al., 2011) . The latter interaction requires the N-terminal region of IFIT3, which is structurally similar to TRIF-NTD, and two glutamate residues at the end of the 9 helix of IFIT3 have been shown to be critical for the interaction with TBK1. Although TRIF-NTD is not required for TRIF-TBK1 interaction, the end of the equivalent 7 helix contains residues with similar properties, including two aspartates (Fig. 4a) , and the surface region also has an electronegative charge. Overall, the similarity between the structures of TRIF-NTD and of the N-terminal region of IFIT proteins may suggest that they have functionally similar roles, which is consistent with the previously proposed regulatory role for TRIF-NTD in TRIF signalling .
Identification of possible binding sites in TRIF-NTD involved in TRIF auto-regulation and binding to signalling partners
One of the suggested functions for TRIF-NTD is binding to the TRIF TIR domain as part of the auto-regulatory mechanism . The amino-acid sequence of TRIF-NTD is highly conserved in mammals, with sequence identities ranging from 63 to 100% (Fig. 4a ). The equivalent regions in TRIF variants from bird and fish species only share 34-37% and 24-28% identity with human TRIF, respectively, but many of the strictly conserved residues are buried and are critical for stabilizing the structure (Fig. 4b and Supplementary Fig. S9 ), suggesting that they have an analogous fold to human TRIF-NTD. To identify possible binding sites involved in TRIF auto-regulation, we looked for surface regions TRIF-NTD shares structural similarity with IFIT proteins. (a) Crystal structure of IFIT5 (PDB entry 4hoq; Abbas et al., 2013) . The N-terminal, central and C-terminal regions are shown in pink, yellow and green, respectively. (b) TRIF-NTD structure in the same orientation as IFIT5 in (a). Subdomains 1 and 2 are displayed in orange and teal, respectively. (c) Superposition of IFIT5 and TRIF-NTD. Only helices 1-9 are shown for IFIT5. present in the structure that exhibited a high degree of sequence conservation among TRIF orthologues. Two programs, ProFunc (Laskowski et al., 2005) and ESPript (Gouet et al., 2003) , were used to consider both sequence and structural information from mammalian TRIF species and diverse TRIF sequences from mammals, birds and fish (Fig. 4) . Surface calculations using ProFunc identified two major clefts with a cutoff volume of >700 Å 3 . The two clefts are located next to each other and may be considered as a continuous surface feature. The largest cleft has a volume of 1500 Å 3 and is localized at the junction between the two helical subdomains (Fig. 5b) . This cleft has a length of 30 Å and a width of 6-12 Å , which could accommodate a six-to-eight-residue polypeptide chain with extended secondary structure. The side walls of this cleft consist of residues from the 3, 5, 7 and 8 helices and the loop connecting the 5 and 6 helices, whereas the base of the pocket is mostly formed by helix 6, the loop connecting the 2 and 3 helices and the end of the loop connecting the 5 and 6 helices. This cleft has significant sequence conservation within mammals, but not between mammals, birds and fish ( Figs. 5b and 5c ), which may suggest that in these two cases the cleft has evolved to accommodate different binding partners or that the binding partner differs substantially between mammals on the one hand and bird and fish species on the other. The most highly conserved residues within the pocket in mammalian TRIF are localized deep in the cleft and include several hydrophobic residues (Leu42, Val69, Val92, Trp94, Ala95 and Leu99; Fig. 5e ). The walls and regions surrounding the pocket include several conserved polar and charged residues including Gln40, Asp67, Glu87, Glu88, Asp91, Arg132, Glu135 and Glu139 (Fig. 5d ). Overall, the base of the cleft is highly hydrophobic, while the entry and exit points have a negative charge. The second cleft is significantly smaller than cleft 1 and includes residues from the 2, 6 and 8 helices and the loop connecting the 2 and 3 helices ( Fig. 5b) . Residues Lys29, Leu43, Leu102, Leu103, Glu105 and Glu106, which are conserved or similar in mammals, birds and fish, form the floor and walls of one half of cleft 2 (Fig. 5b) . These residues are also part of an extended surface patch on the top face of the molecule with high similarity in mammalian, bird and fish TRIF species, suggesting that this region of the TRIF-NTD molecule might also function as an interaction surface (Fig. 5b) . In addition to the conserved residues in cleft 2, this surface patch consists of residues Ile14, Ala17, Ala18, Lys22, Ile59, Ala104, Lys107, Leu108 and Cys109.
Conclusions
In this study, we present the structural and functional characterization of the NTD of the TLR signalling adaptor TRIF. We determined the crystal structure of the protease-resistant TRIF-NTD (residues 1-153) at 2.22 Å resolution by using SAD phasing with an SeMet-labelled protein containing two additional introduced Met residues. The structure shows two helical subdomains connected by a 14-residue linker. The helix pairs resemble TPR-like motifs and the overall fold of TRIF-NTD shares significant structural similarity with the IFIT family of proteins, which are also involved in innate immune signalling. The structure suggests possible surfaces that could mediate the interaction with the TIR domain as part of the proposed auto-regulatory mechanism or possibly with unknown interaction partners. Based on the similarities to IFIT proteins and to TPR proteins in general, TRIF-NTD could serve as the sensor domain for an as-yet unknown ligand, with the interaction exposing the binding sites for TBK1, resulting in type 1 IFN signalling. This would also be consistent with the data showing that the deletion of TRIF-NTD leads to increased IFN production and is also similar to mechanisms proposed for PRRs such as NLRs and plant resistance (R) proteins, in which the LRR domain has a dual sensor and auto-regulatory role. Significantly, exogenous TRIF-NTD suppressed the activation of both the IFN and NF-B promoters, providing further evidence for the autoregulatory role of NTD in TRIF and suggesting that our construct could serve as a therapeutic reagent targeting TLR3and TLR4-mediated inflammation.
